Capillary Technologies India Ltd

Mirae Asset Mutual Fund has disclosed the sale of 175,842 shares, representing 0.22% of the total share capital, in Capillary Technologies India Ltd. The transaction, which occurred on September 15, 2026, via open market, reduced Mirae Asset Mutual Fund's holding to 1,032,363 shares, or 1.25% of the total share capital. The total equity share capital of Capillary Technologies before the sale was ₹79,471,983.

Capillary Technologies India Ltd announced the appointment of seven new Senior Management Personnel (SMP) following a circular resolution by its Board of Directors on September 1, 2026. The appointments, approved based on recommendations from the Nomination and Remuneration Committee, include key roles such as Director - Finance (Corporate Development), Vice President – Customer Success, President - Middle East, Africa & India, Vice President - Legal, Vice President - Finance, and Chief of Staff (Corporate). These appointments aim to strengthen the company's leadership across various critical functions and regions.

Capillary Technologies India Ltd has issued a clarification regarding a transaction undertaken by its promoter entity, Capillary Technologies International Pte. Ltd. (CTIPL). The transaction involved approximately 4% of the company's equity share capital and was executed on August 10, 2026. This was part of a secondary market transaction to facilitate the exit of Peak XV Partners, an early-stage institutional private equity investor in CTIPL. The company emphasizes that this does not represent an exit by operational founders or a reduction in their commitment. The transaction occurred at the promoter entity level due to the liquidity event of an institutional investor and is part of the normal lifecycle of private equity investments. Institutional investors hold their stake through CTIPL, and such transactions are effected through CTIPL. The core promoter commitment and founders' alignment remain unchanged, with other institutional investors retaining over 30% in CTIPL.

Kotak Mahindra Mutual Fund (KMMF) has acquired a significant stake in Capillary Technologies India Ltd, crossing the 5.00% threshold of the company's issued equity share capital. The acquisition was made through various schemes managed by KMMF. Prior to this transaction, KMMF held approximately 4.9759% of the total voting capital. The latest acquisition adds 93,281 shares, representing 0.1174% of the voting capital, bringing their total holding to over 5%. This disclosure is made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Capillary Technologies International Pte Ltd (CTIPL), a promoter of Capillary Technologies India Limited, has disposed of 3,292,428 equity shares, representing 4.14% of the company's total paid-up equity share capital. The sale occurred through a block deal on the stock exchange. Following the transaction, CTIPL's shareholding in the company has reduced from 48.92% to 44.78%. CTIPL continues to be a promoter of Capillary Technologies India Limited.

Capillary Technologies International Pte Ltd (CTIPL), a promoter of Capillary Technologies India Limited, has disclosed the sale of 3,292,428 equity shares, representing 4.14% of the total paid-up equity share capital. The transaction was executed via a block deal on the stock exchange on August 10, 2026. Following this disposal, CTIPL's shareholding in the Target Company has reduced from 48.92% to 44.78%. CTIPL continues to be a promoter of the company. The total equity share capital of the company before and after the sale was 79,471,983 shares.

Capillary Technologies, through its subsidiary Capillary Pte Ltd, has acquired the CustomerGlu software platform and associated intellectual property from Marax AI, Inc. This strategic acquisition integrates CustomerGlu's interactive engagement layer with Capillary's AI core to create a next-generation platform for AI-powered loyalty and customer engagement. The move aims to eliminate engineering bottlenecks, enable marketers to launch interactive UI experiences in real-time, and enhance customer retention for enterprise brands globally. CustomerGlu, founded by Prateek Gupta, Raman Shrivastava, and Sumant Subrahmanya, leverages GenAI to predict buying behavior and trigger gamified actions, bypassing IT dependencies for clients.

Capillary Technologies India Ltd announced its Q1 FY2027 financial results, reporting a significant 43% year-on-year growth in operating revenue to ₹2,566.4 Million. This growth was driven by expansion within its existing customer base, new annual contract value contributions, and the recent acquisition of SessionM. Adjusted EBITDA surged by 132% to ₹440.2 Million. Normalized Profit After Tax (PAT) also saw exponential growth of 3,320% to ₹254.4 Million, attributed to operational efficiencies and integration synergies. The company highlighted strong Net Retention Rate expansion and the successful integration of SessionM as key drivers for future growth.

Capillary Technologies India Limited announced that its Board of Directors has approved the unaudited financial results (Standalone and Consolidated) for the quarter ended June 30, 2026. The board meeting commenced at 10:30 AM IST and concluded at 1:05 PM IST on August 04, 2026. The company also confirmed that the trading window for dealing in its securities, which was closed from July 01, 2026, will re-open 48 hours after the declaration of these financial results. The financial results and the limited review report are available on the company's website.

Capillary Technologies' consolidated Q1 FY27 (quarter ended 30 June 2026) revenue rose 42.7% YoY and 34.1% QoQ to ₹256.64 Cr, lifted by SessionM's consolidation from 1 May 2026 alongside organic growth. Yet the group reported a consolidated net LOSS of ₹9.55 Cr, reversing a ₹43.36 Cr profit in Q4 FY26 and a marginal ₹0.75 Cr profit a year ago. The swing was driven entirely by a ₹33.39 Cr (€3.04 million) exceptional expense — a cyber-enabled banking fraud at SessionM Czech Republic s.r.o, the Czech step-down subsidiary acquired with SessionM, which saw unauthorised bank transfers during the quarter. Strip that out and pre-tax operating profit (before exceptional items) was ₹24.80 Cr, up 41.6% QoQ from ₹17.52 Cr and up sharply from a near-breakeven ₹0.55 Cr a year ago — underlying profitability improved even as the headline print shows red. Adjusted net margin still compressed, to roughly 9.3% from ~21.9% in Q4 FY26 (per prior record), as employee costs jumped to ₹119.84 Cr (+33.8% QoQ) on SessionM integration and, per management's own pre-results commentary, routine annual salary increments; professional/consultancy and software & server costs also rose with the wider group perimeter. This tracks the prior guidance that FY27 margins would see near-term dilution from acquisition integration even as absolute EBITDA grows: profit before D&A/finance/exceptional items (₹46.01 Cr) rose 20.7% QoQ — absolute profitability up, percentage margin down, exactly the pattern flagged on the May 2026 concall. Management's claim that core (non-acquired) business margins continue to expand cannot be independently verified from the filing's single-segment P&L. On an annualised run-rate basis, the quarter's ₹256.64 Cr revenue tracks to roughly ₹1,026 Cr for FY27 — squarely inside management's guided ₹1,000-1,050 Cr band, so revenue guidance is on track. No formal Street consensus for this specific quarter was found in a web search; commentary on FY27 broadly expects 15-20% full-year PAT growth, a bar the fraud-hit reported number doesn't address but the ex-exceptional print is tracking toward. Standalone (the India entity alone, insulated from the Czech subsidiary loss) stayed solidly profitable at ₹7.77 Cr PAT — down from ₹9.90 Cr in Q4 FY26 but a turnaround from a ₹5.12 Cr loss a year ago — underscoring that the reported group loss is subsidiary-specific, not a standalone-business problem. The quarter also saw a forensic audit initiated (31 July 2026) into the same banking fraud and a senior management resignation (27 July 2026) disclosed just days before results. The company states the fraud investigation, banking-authority freeze (~₹4.67 Cr recovered so far) and insurance claim are ongoing, with further disclosure to follow as they resolve. The board separately approved the FY26 annual report, BRSR filing, and called the 14th AGM for 28 August 2026 alongside these results.